Alice Fitzpatrick

Preclinical and translational biologist advancing metabolic disease programs from early discovery through CTA-enabling studies. Experienced in building and scaling internal research functions, integrating in vivo, ex vivo, and bioanalytical platforms, and leading cross-functional teams and external partners to deliver high-quality data on time. At Fractyl, progressed from Principal Scientist to Director, establishing capabilities, directing proof-of-concept and safety studies, and supporting regulatory milestones. Passionate about bridging mechanistic biology with clinical translation and developing high-performing scientific teams.